Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment, » Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read More
Alert: 77.7% Upside In Under-the-Radar Growth Stock
Investment Alert: Buy dLocal Under $13
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Growth stocks aren’t in vogue right now but some exhibit growth rates so high that they can’t help but seize your attention.
» Read more about: Alert: 77.7% Upside In Under-the-Radar Growth Stock »
Read More
Market Commentary: 19 Stocks with Ridiculous Cash Flows
When the economic winds of fortune change, the old saying goes that cash is king but maybe it should be cash flows are king. A company that can spit out enormous sums of cash with predicability may offer a safe haven at a perilous time. To find out what companies stand out, a little-known metric called CROCI is very useful.
» Read more about: Market Commentary: 19 Stocks with Ridiculous Cash Flows »
Read MoreAlert: Billionaire Bets BIG On Under-the-Radar Stock
Investment Alert: Buy Global Payments [GPN] Under $100/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Larry Robbins isn’t a name that most investors know well,
» Read more about: Alert: Billionaire Bets BIG On Under-the-Radar Stock »
Read More
1 Rare Stock Buffett Is Buying
Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).
These purchases brought Berkshire Hathaway’s holdings in Verisign to 13.2 million shares,
» Read more about: 1 Rare Stock Buffett Is Buying »
Read MoreThe Ivy
Could Meta Be the Next $2 Trillion Titan?
With over 3.4 billion people engaging with at least one of Meta’s apps daily, the company already owns the world’s largest digital attention network. But now, it’s not just about scale, it’s about intelligence. Meta has embedded AI deep into its core product experiences, reshaping how users interact with content and how advertisers connect with audiences.
» Read more about: Could Meta Be the Next $2 Trillion Titan? »
Read MoreThe Spotlight
Spotlight: Market Crash Incoming?
Some stock market indicators are better than others but have you heard of one being perfect for over a century? If the cyclically adjusted price-to-earnings ratio, better known as CAPE, is to be believed, then the markets could be set for a rocky road this year.
Unlike traditional PE ratios, the CAPE figure factors in inflation and smooths the peaks and troughs of unforeseen or surprising events –
» Read more about: Spotlight: Market Crash Incoming? »
Read MoreThe Daily
Bursa slips at the open as quiet trade follows Wall Street’s Thanksgiving pause
KUALA LUMPUR, Nov 28 — Bursa Malaysia’s benchmark index opened almost flat on Friday and drifted lower in early trade amid muted sentiment and the absence of fresh catalysts following Wall Street’s Thanksgiving closure.
At 9.07am, the FTSE Bursa Malaysia KLCI (FBM KLCI) fell 2.97 points, or 0.18 per cent, to 1,614.49 from Thursday’s close of 1,617.46.
» Read more about: Bursa slips at the open as quiet trade follows Wall Street’s Thanksgiving pause »